[CLAG regimen in combination with sorafenib in the treatment of refractory acute myeloid leukemia:a case report].
Department of Hematology, the Affiliated Cancer Hospital of Zhengzhou University; Henan Cancer Hospital, Zhengzhou 450008, China.
Hao
H
Xu
Department of Hematology, the Affiliated Cancer Hospital of Zhengzhou University; Henan Cancer Hospital, Zhengzhou 450008, China.
Xudong
X
Wei
Department of Hematology, the Affiliated Cancer Hospital of Zhengzhou University; Henan Cancer Hospital, Zhengzhou 450008, China.
Qingsong
Q
Yin
Department of Hematology, the Affiliated Cancer Hospital of Zhengzhou University; Henan Cancer Hospital, Zhengzhou 450008, China.
Ruihua
R
Mi
Department of Hematology, the Affiliated Cancer Hospital of Zhengzhou University; Henan Cancer Hospital, Zhengzhou 450008, China.
Ping
P
Wang
Department of Hematology, the Affiliated Cancer Hospital of Zhengzhou University; Henan Cancer Hospital, Zhengzhou 450008, China.
Hao
H
Ai
D000971:Antineoplastic Combined Chemotherapy Protocols; D006801:Humans; D015470:Leukemia, Myeloid, Acute; D009536:Niacinamide / Q000031:analogs & derivatives; D010671:Phenylurea Compounds; D000077157:Sorafenib
D010671:Phenylurea Compounds; D009536:Niacinamide; D000077157:Sorafenib